Archives
-
Protease and Phosphatase Inhibitor Cocktail Guide
2026-09-15
Preserve both protein abundance and phosphorylation state during macrophage, tissue, and microbial lysate preparation with an EDTA-free 100X formulation. This workflow shows how to protect HMGB1-centered signaling assays while maintaining compatibility with experiments where metal chelation is undesirable.
-
Deferiprone Workflows for Iron-Stress Biology
2026-09-15
Build controlled iron-depletion experiments with Deferiprone for cancer biology, enterocyte metabolism, oxidative stress, and vascular models. This workflow combines dose optimization, time-resolved transcription, metabolic profiling, inflammatory challenge, and iron repletion to distinguish iron-specific effects from nonspecific toxicity.
-
Bradykinin BA5201: Reliable Cell Assay Workflows
2026-09-14
This scenario-driven guide explains how Bradykinin, SKU BA5201, can be integrated into endothelial, smooth-muscle, permeability, inflammation, and cell-viability workflows without confusing biological activity with assay toxicity. It covers experimental controls, exploratory parameters, peptide handling, interpretation, and practical vendor-selection criteria.
-
Hepatic sEH, Nrf2, and Osteoclastogenesis
2026-09-14
The reference study identifies a liver–bone axis in which hepatic soluble epoxide hydrolase alters circulating 14,15-EET and 14,15-DHET, suppresses Nrf2-ARE signaling, and promotes osteoclast differentiation. By combining patient samples, an ovariectomy-induced osteoporosis model, liver-specific sEH knockdown, pharmacological inhibition, and transcriptomics, it provides a mechanistic framework for studying redox imbalance in bone remodeling.
-
RSL3 GPX4 Inhibitor: Ferroptosis Workflows
2026-09-13
RSL3 provides a direct way to test whether GPX4 dependence, iron accumulation, and lipid oxidation control cancer-cell survival. This practical guide connects ferroptosis assays with TEAD2 biology, oncogenic RAS synthetic lethality, and reproducible troubleshooting for cell and xenograft studies.
-
Intravesical p21 mRNA-LNP Therapy for Bladder Cancer
2026-09-12
This FASEB Journal study developed chemically modified CDKN1A/p21 mRNA encapsulated in lipid nanoparticles for localized intravesical treatment of bladder cancer. The approach restored nuclear p21 expression, altered cell-cycle and DNA-damage signaling, and reduced orthotopic tumor growth in mice while limiting systemic distribution.
-
DAPI Nuclear Stain Solution: Workflow Guide
2026-09-11
DAPI (4',6-Diamidino-2-Phenylindole) Nuclear Stain Solution, SKU K2402, provides a ready-to-use fluorescent DNA binding dye for nuclear visualization and endpoint cell viability assessment. It is most appropriate for fixed or membrane-compromised cells analyzed by fluorescence microscopy or flow cytometry, rather than routine imaging of intact live cells.
-
PF-573228: Reading FAK Signals in Stiff Matrices
2026-09-11
A translational framework for using PF-573228 to test whether substrate stiffness drives odontoblast differentiation through the LAMB1–FAK–MEK1/2 axis, while extending the logic to cancer and endothelial models.
-
SHH and FGF Control Penile Development Across Species
2026-09-10
A 2025 comparative study shows that species-specific penile development is associated with differences in Shh, Fgf10, and Fgfr2 expression, rather than being explained by anatomy alone. Its combination of spatial gene-expression analysis, quantitative PCR, and genital-tubercle culture identifies pathway dosage and timing as important determinants of prepuce and urethral groove formation.
-
CDK9 inhibitor A3294: Protocol and QC Guide
2026-09-10
CDK9 inhibitor A3294 provides a selective serine/threonine kinase inhibitor for studying CDK9-dependent transcription elongation and HIV-1 propagation inhibition. It is intended for controlled biochemical and cellular assays, not pan-CDK experiments or long-term storage of prepared solutions.
-
Phosbind Acrylamide for Signaling Decisions
2026-09-09
A translational framework for using antibody-free mobility shifts to investigate phosphorylation-dependent regulation, illustrated through the RpfG–HtsH signaling architecture in Lysobacter enzymogenes.
-
HRP Goat Anti-Rabbit IgG (H+L) Antibody Guide
2026-09-09
HRP Goat Anti-Rabbit IgG (H+L) Antibody (SKU K1223) provides an HRP-labeled secondary reagent for detecting rabbit IgG in Western blot, ELISA, IHC, and IC workflows. It should be optimized for each assay and is intended for research use only, not diagnostic or medical applications; no directly matched paper evidence is supplied for this product.
-
AY 9944 dihydrochloride: Causal Sterol Biology
2026-09-08
AY 9944 dihydrochloride enables controlled DHCR7 inhibition and interpretable 7-dehydrocholesterol accumulation studies. This article develops a causal assay framework that connects chemical sterol perturbation with genetic evidence from GCRV-resistant grass carp while clearly separating validated findings from translational hypotheses.
-
L-Glutathione Reduced in Translational Redox Research
2026-09-08
A mechanistic and strategic guide to using L-Glutathione Reduced for redox assay design, GST-affinity workflows, and translational interpretation of GOT1-linked cancer metabolism.
-
Glucocorticoids, Kv2.1, and CaV1.2 Calcium Signals
2026-09-07
The reference study identifies a rapid, non-genomic mechanism by which glucocorticoids suppress hippocampal CaV1.2-mediated calcium signals: reduced cAMP/PKA activity promotes endocytosis of Kv2.1 channel clusters, which in turn alters CaV1.2 surface availability. Its combination of neuronal calcium imaging, electrophysiology, trafficking assays, and Kv2.1 mutant analysis provides a useful framework for separating direct channel effects from cluster-dependent membrane remodeling.